Literature DB >> 16287479

A follow-up study of mortality, health conditions and associated disabilities of people with intellectual disabilities in a Swedish county.

K-H Gustavson1, O Umb-Carlsson, K Sonnander.   

Abstract

BACKGROUND: In the planning of services and health care for individuals with intellectual disability (ID), information is needed on the special requirements for habilitation and medical service and associated disabilities.
MATERIAL AND METHODS: An unselected consecutive series of 82 adult persons with ID was studied. The medical examination consisted of the individual's health condition, associated impairments and disabilities. Medical and habilitation services and support were studied.
RESULTS: The results indicated that 71% of the persons in the series had severe and 29% mild ID. Forty-seven per cent of the persons with severe ID and 35% of those with mild ID had one or more additional central nervous system (CNS) disabilities. Of the persons with ID, 99% had access to a family doctor and 84% attended regular health visits. Notably, half of persons were referred to a specialist examination as a consequence of their present medical examination. Half of the persons with mental health problems were previously undiagnosed and only a few of these had access to a psychiatrist.
CONCLUSION: Our study clearly demonstrates the magnitude and importance of neurological and psychiatric impairments in ID. The findings suggest a strong need for multidisciplinary health service.

Entities:  

Mesh:

Year:  2005        PMID: 16287479     DOI: 10.1111/j.1365-2788.2005.00728.x

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  8 in total

1.  Illness in people with intellectual disabilities.

Authors:  Afia Ali; Angela Hassiotis
Journal:  BMJ       Date:  2008-03-15

2.  The impact of living arrangements and deinstitutionalisation in the health status of persons with intellectual disability in Europe.

Authors:  R Martínez-Leal; L Salvador-Carulla; C Linehan; P Walsh; G Weber; G Van Hove; T Määttä; B Azema; M Haveman; S Buono; A Germanavicius; H van Schrojenstein Lantman-de Valk; J Tossebro; A Carmen-Câra; D Moravec Berger; J Perry; M Kerr
Journal:  J Intellect Disabil Res       Date:  2011-07-05

3.  [Health among persons with intellectual disability in Spain: the European POMONA-II study].

Authors:  Rafael Martínez-Leal; Luis Salvador-Carulla; Mencía Ruiz Gutiérrez-Colosía; Margarida Nadal; Ramón Novell-Alsina; Almudena Martorell; Rodrigo G González-Gordón; M Reyes Mérida-Gutiérrez; Silvia Ángel; Luisa Milagrosa-Tejonero; Alicia Rodríguez; Juan C García-Gutiérrez; Amado Pérez-Vicente; José García-Ibáñez; Francisco Aguilera-Inés
Journal:  Rev Neurol       Date:  2011-10-01       Impact factor: 0.870

4.  Unmet Needs of Adults in Community Mental Health Care With and Without Intellectual and Developmental Disabilities: A Cross-Sectional Study.

Authors:  Anna Durbin; Frank Sirotich; Yona Lunsky; Janet Durbin
Journal:  Community Ment Health J       Date:  2015-10-19

5.  The oral health status of 4,732 adults with intellectual and developmental disabilities.

Authors:  John P Morgan; Paula M Minihan; Paul C Stark; Matthew D Finkelman; Konstantina E Yantsides; Angel Park; Carrie J Nobles; Wen Tao; Aviva Must
Journal:  J Am Dent Assoc       Date:  2012-08       Impact factor: 3.634

6.  An estimation of the prevalence of intellectual disabilities and its association with age in rural and urban populations in India.

Authors:  Ram Lakhan; Olúgbémiga T Ekúndayò; Mohammad Shahbazi
Journal:  J Neurosci Rural Pract       Date:  2015 Oct-Dec

7.  Mortality patterns and risk among older men and women with intellectual disability: a Swedish national retrospective cohort study.

Authors:  Nawi Ng; Eva Flygare Wallén; Gerd Ahlström
Journal:  BMC Geriatr       Date:  2017-11-22       Impact factor: 3.921

8.  Health care utilisation among older people with Down syndrome compared to specific medical guidelines for health surveillance: a Swedish national register study.

Authors:  G Ahlström; A Axmon; M Sandberg; E Flygare Wallén
Journal:  BMC Health Serv Res       Date:  2020-10-15       Impact factor: 2.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.